
Opinion|Videos|April 7, 2025
Managing Early HER2+ mBC: Patient-Centered Approaches and Evolving Treatment Strategies
Experts discuss how, it is crucial to approach treatment strategies with both compassion and transparency. It is important to explain the complexity of the situation and maintain clear and accessible language when discussing treatment strategies with patients and their families.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- What have been your care strategies for brain metastasis that are beneficial for the patients and their families.
Advertisement
Related to this article

After a run of 2026 oral SERD approvals, Erica L. Mayer, MD, MPH, discusses ESR1 testing and a possible adjuvant role for giredestrant.

Lisa Carter-Bawa, PhD, MPH, APRN, describes how AI could flag patients eligible for lung screening and why nurses must stay the human in the loop.

An ONS nursing practice leader shares takeaways from EONS19 at ESMO 2026, from workforce sustainability to new therapies and subcutaneous care.

Erica L. Mayer, MD, MPH, explains what the all-oral giredestrant plus everolimus regimen asks of patients and oncology nurses between clinic visits.

JoAnne Page, RN, a breast cancer survivor, shares what oncology nurses can do for care partners of patients with bladder cancer.

Lisa Carter-Bawa, PhD, MPH, APRN, explains how blame keeps patients from lung cancer care and how nurses can counter that stigma in the community.

At the 10th Annual School of Nursing Oncology, faculty said nurses need fast, disease-specific updates to educate patients and manage novel therapies.
Advertisement
Advertisement
Trending on Oncology Nursing News
1
Workplace Violence in Oncology: What Nurses Need to Know
2
New ASH Myelofibrosis Guidelines: Key Points for Nurses and APPs
3
Oral SERDs: What Giredestrant Signals for Nurses
4
AI Can Help Find Patients for Lung Screening, but Nurses Stay in the Loop
5



